The Patent Finder

Terms ending in 2040

Amgen Inc.

Every in-force patent on Amgen Inc.'s record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,986,624Insertion Mechanism for Drug Delivery Device
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 11,433,402Magnetic Assisted Separation Apparatuses and Related Methods
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 11,807,624Substituted Pyrimidinones as Agonists of the Apj Receptor
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 11,299,491Synthesis of Key Intermediate of Kras G12C Inhibitor Compound
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 12,391,689Synthesis of Key Intermediate of Kras G12C Inhibitor Compound
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 12,612,366Salts and Crystal Forms of Omecamtiv Mecarbil
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 11,672,733Gas Permeable Sealing Member for Drug Container and Methods of Assembly
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 12,178,991Wearable Injector with Sterile Adhesive Patch
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US D1,065,512Autoinjector with Removable Cap
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 12,552,877ANTI-TL1A Antibodies and Uses Thereof
In force
 · High confidence
Amgen Inc.In forceHigh confidence
55 more term ends in 2040 · Pro
10 of 65 patents shown. Soonest term end first, then patent number.
Pro members see all 65.
Upgrade to Pro
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited